What is Caliway Biopharmaceuticals Co., Ltd's contact information?

Caliway Biopharmaceuticals Co., Ltd's contact information: info@caliwaybiopharma.com, +886 2 2697-1355, +886226971355.

How many employees does Caliway Biopharmaceuticals Co., Ltd have?

Caliway Biopharmaceuticals Co., Ltd has 19 employees.

What industry does Caliway Biopharmaceuticals Co., Ltd belong to?

Caliway Biopharmaceuticals Co., Ltd is in the industry of: Pharmaceuticals, Biotechnology, Health, Wellness And Fitness.

What are Caliway Biopharmaceuticals Co., Ltd's official social media profiles?

Caliway Biopharmaceuticals Co., Ltd Linkedin Page

What tech stack does Caliway Biopharmaceuticals Co., Ltd use?

Some of the popular technologies that Caliway Biopharmaceuticals Co., Ltd uses are: Facebook Login, Font Awesome, jQuery, jQuery UI, Slick, scrollreveal, imagesLoaded.

What are Caliway Biopharmaceuticals Co., Ltd's office addresses?

Caliway Biopharmaceuticals Co., Ltd has 2 known office addresses: 新北市汐止區新台五路一段99號32樓之9 汐止區新台五路一段99號32樓之9, 新北市, 22175, Tw.

What is Caliway Biopharmaceuticals Co., Ltd's open headcount?

Caliway Biopharmaceuticals Co., Ltd has no job postings yet.

What is the number of ad campaigns for Caliway Biopharmaceuticals Co., Ltd?

Caliway Biopharmaceuticals Co., Ltd has no advertisements yet.

What is the number of recent news articles about Caliway Biopharmaceuticals Co., Ltd?

Caliway Biopharmaceuticals Co., Ltd has 10 news articles.

Caliway Biopharmaceuticals Co., Ltd - Pubrio Company Profile & Intent

Caliway Biopharmaceuticals Co., Ltd

Taiwan · Pharmaceuticals

Pharmaceuticals

Biotechnology

Health, Wellness And Fitness

康霈生技專精於醫美與慢性發炎疾病的新藥開發，並鎖定市場達 100 億美金以上，且現有治療方式或藥物療效不佳、副作用明顯或無核准治療藥物的適應症來開發藥物，再透過創新且專一藥理機制，來滿足上述市場需求。公司擁有傑出的經營與研發團隊，並集結國內、外專家學者及醫美權威醫師擔任顧問，致力於突破現有藥物的困境，提供更有效且安全的治療方案。

Company Insights

prnasia.com · recognized_as · 18 hours ago

Open news

Caliway's CBL-514 Research Selected for ADA

Caliway Biopharmaceuticals' preclinical research on CBL-514 combined with GLP-1R therapies selected for presentation at ADA 2026 Scientific Sessions by Dr. W. Timothy Garvey, highlighting metabolic medicine potential.

prnasia.com · recognized_as · 2026-01-26

Open news

CBL-514 for Dercum's Disease published in JAAD International

Caliway Biopharmaceuticals' CBL-514 for Dercum's Disease shows significant efficacy in Phase 2 clinical trial, published in JAAD International.

prnasia.com · launches · 2025-12-05

Open news

Caliway's CBL-514 shows synergy with GLP-1 for weight management

Caliway's CBL-514 shows synergistic effects with GLP-1 drugs for weight management, offering better weight loss and maintenance than GLP-1 alone.

khgames.co.kr · is_developing · 2026-03-03

Open news

Bitcoin option investors bet on downside despite price rise

Bitcoin ETF and crypto-holding firms are buying put options to hedge against potential price drops below $60,000, despite recent price increases.

khgames.co.kr · is_developing · 2026-03-03

Open news

Bitcoin's 'Death Cross' Appears: Future Trends?

Bitcoin chart shows 'death cross' pattern, historically preceding major price drops. Despite this, ETFs see $1 billion inflow and long-term investors continue accumulating.

coinreaders.com · launches · 2026-03-02

Open news

JPMorgan: Crypto Market Structure Act likely to pass mid-year

JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.

Get full access to view complete information

1 - 10 of 10

Frequently Asked Questions Regarding Caliway Biopharmaceuticals Co., Ltd

Company Overview

2012

Founded

Pharmaceuticals

Industry

Taiwan

Location

4,372,023

Ranking

19 employees

Size

Similar Companies

Get full access to view complete information